Clinical Trial Update: Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the feasibility of using circulating tumor DNA–based minimal residual disease to guide adjuvant therapy in locally advanced ga…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Gastric / Gastroesophageal Junction Adenocarcinoma | Phase 3 | Status: NOT_YET_RECRUITING